In vitro susceptibility study of micelial fungal and yeast isolates to itraconazole and voriconazole

Keyphrases

• Aspergillus Fumigatus 11%
• Azoles 11%
• Candida 11%
• Candida Glabrata 11%
• Cryptococcus Neoformans 11%
• Filamentous Form 11%
• Filamentous Fungi 11%
• Fluconazole-resistant Candida Albicans 11%
• Fungal Isolates 100%
• Fungal Species 11%
• High Susceptibility 11%
• In Vitro Activity 11%
• In Vitro Susceptibility 100%
• Intravenous Formulation 11%
• Itraconazole 100%
• MIC90 11%
• NCCLS 11%
• Rhizopus Stolonifer 11%
• Scedosporium 22%
• Sporothrix Schenckii 11%
• Statistical Significance 11%
• Voriconazole 100%
• Yeast Isolate 100%

Immunology and Microbiology

• Aspergillus fumigatus 20%
• Candida 20%
• Candida Albicans 20%
• Candida Glabrata 20%
• Cryptococcus neoformans 20%
• Filamentous Fungus 20%
• In Vitro 100%
• Lomentospora prolificans 20%
• MIC90 20%
• Minimum Inhibitory Concentration 20%
• Rhizopus Stolonifer 20%
• Scedosporium 20%
• Susceptibility 100%

Pharmacology, Toxicology and Pharmaceutical Science

• Aspergillus fumigatus 11%
• Candida 11%
• Candida Albicans 11%
• Candida Glabrata 11%
• Cryptococcus neoformans 11%
• Filamentous Fungus 11%
• Fluconazole 11%
• Itraconazole 100%
• Lomentospora prolificans 11%
• Pyrrole Derivative 11%
• Rhizopus Stolonifer 11%
• Scedosporium 11%
• Voriconazole 100%